menu
    • menu

    Company profile for LIR Life Sciences

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LIR Life Sciences is a biotechnology company focused on transforming obesity treatment through innovative drug-delivery technologies. We are developing scalable, affordable transdermal and alternative GLP-1-based therapies designed to improve accessibility, convenience, and adherence while reducing reliance on injections. Guided by science and driven by innovation, LIR aims to expand access to effective obesity care worldwide ...
    LIR Life Sciences is a biotechnology company focused on transforming obesity treatment through innovative drug-delivery technologies. We are developing scalable, affordable transdermal and alternative GLP-1-based therapies designed to improve accessibility, convenience, and adherence while reducing reliance on injections. Guided by science and driven by innovation, LIR aims to expand access to effective obesity care worldwide and address unmet needs in metabolic health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LIR Life SciencesCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1505 W 2nd Ave, Suite 506 Vancouver, BC, V6J1H2
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lirlife.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuland, LIR Partner to Advance Cell Penetrating Peptide Platform
    Neuland, LIR Partner to Advance Cell Penetrating Peptide Platform

    08 May 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/neuland-laboratories-partners-with-lir-life-sciences-for-transdermal-glp-1-peptide-development/

    EXPRESSPHARMA
    08 May 2026
    Share Share
    LIR Life Sciences Begins Study on Enhanced Transdermal Delivery
    LIR Life Sciences Begins Study on Enhanced Transdermal Delivery

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/lir-life-sciences-launches-ex-vivo-animal-study-to-evaluate-protamine-enhanced-transdermal-transport

    PHARMIWEB
    28 Apr 2026
    Share Share
    LIR Life Sciences Corp. Partners With Resilience Biosciences
    LIR Life Sciences Corp. Partners With Resilience Biosciences

    20 Apr 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lir-life-sciences-corp.-announces-agreement-with-resilience-biosciences-inc.-1159110

    ACCESSWIRE
    20 Apr 2026
    Share Share
    LIR Life Sciences: Positive CPP Transdermal GLP/GIP Data Reported
    LIR Life Sciences: Positive CPP Transdermal GLP/GIP Data Reported

    29 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lir-life-sciences-reports-positive-interim-preclinical-results-from-comparative-anima-1131724

    ACCESSWIRE
    29 Jan 2026
    Share Share
    LIR Life Partners with Neuland Labs on Transdermal GLP-1/GIP
    LIR Life Partners with Neuland Labs on Transdermal GLP-1/GIP

    08 Jan 2026

    // PRESS RELASE

    https://webfiles.thecse.com/01082026_PR_SKNY_Partnership_with_Neuland_Laboratories.pdf?DXu7BYsbNOsaKswqRPmJ2_mKq_lDXtzG

    PRESS RELASE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search